Cozaar and Miralax drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Cozaar (losartan potassium) and Miralax (polyethylene glycol 3350). Common drug interactions include pneumonia among females and pain among males.
The phase IV clinical study analyzes what interactions people have when they take Cozaar and Miralax. It is created by eHealthMe based on reports of 723 people who take the same drugs from the FDA, and is updated regularly.
What is Cozaar?
Cozaar has active ingredients of losartan potassium. It is often used in high blood pressure. eHealthMe is studying from 45,124 Cozaar users. Check the latest studies of Cozaar.
What is Miralax?
Miralax has active ingredients of polyethylene glycol 3350. It is often used in constipation. eHealthMe is studying from 81,754 Miralax users. Check the latest studies of Miralax.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
723 people who take Cozaar and Miralax together, and have interactions are studied.
What are the common drug interactions of Cozaar and Miralax, by gender? *
What are the common drug interactions of Cozaar and Miralax, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Cozaar and Miralax?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Cozaar and Miralax:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Cozaar:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Miralax:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Cozaar and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Miralax and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Lai SW, Lin HF, Lin CL, Liao KF, "No association between losartan use and acute pancreatitis in hypertensive patients", Eur J Hosp Pharm, 2017 Mar .
- Lai SW, Lin HF, Lin CL, Liao KF, "No association between losartan use and acute pancreatitis in hypertensive patients", Eur J Hosp Pharm, 2017 Mar .
How the study uses the data?
The study uses data from the FDA. It is based on losartan potassium and polyethylene glycol 3350 (the active ingredients of Cozaar and Miralax, respectively), and Cozaar and Miralax (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Provera and Suicidal Thoughts for Women aged 20-29 - now
- Provera and Suicidal Ideation for Women aged 20-29 - a second ago
- Drug interactions of Bendamustine and Ibuprofen - a second ago
- Sinus Bradycardia and drugs of ingredients of filgrastim - 3 seconds ago
- Could Polyethylene Glycol 3350 cause Hyponatremia? - 3 seconds ago
- Generalized Anxiety Disorder and drugs of ingredients of cefuroxime sodium - 4 seconds ago
- Drug interactions of Prialt and Clonidine - 5 seconds ago
- Electrolyte Imbalance and drugs of ingredients of troglitazone - 8 seconds ago
- Could Paracetamol cause Thyrotoxic Crisis? - 9 seconds ago
- Death and drugs of ingredients of mivacurium chloride - 9 seconds ago